Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Review Question - QID 102974

In scope icon M 11 E
QID 102974 (Type "102974" in App Search)
a 34-year-old G2P2 woman presents to her obstetrician because of new onset discharge from her breast. She first noticed it in her bra a few days ago, but now she notes that at times she's soaking through to her blouse, which is mortifying. She was also concerned about being pregnant because she has not gotten her period in 3 months. In the office ß-HCG is negative. The patient's nipple discharge is guaiac negative. Which of the following therapies is most appropriate?

Tamoxifine

0%

0/4

Leuprolide

0%

0/4

Haloperidol

0%

0/4

Cabergoline

100%

4/4

Carbidopa-levodopa

0%

0/4

Select Answer to see Preferred Response

bookmode logo Review TC In New Tab

This patient has galactorrhea and amenorrhea, with a negative pregnancy test; which is highly suggestive of hyperprolactinemia. Appropriate therapy is with dopamine agonists such as cabergoline or bromocriptine.

Hyperprolactinemia, or elevated serum prolactin, is a common condition often due to pregnancy, medication side-effects, or prolactin secreting pituitary tumors (prolactinoma). If unrecognized, hyperprolactinemia can result in hypogonadism, infertility, and eventually galactorrhea. Aside from reproductive symptoms, patients with prolactinomas may present with headaches and if it's large enough, bitemporal hemianopsia due to mass effect on the optic chiasm. Diagnosis is through serum prolactin levels being >250 mcg/L. Medical therapy is directed at suppressing prolactin secretion via dopamine agonists such as cabergoline or bromocriptine.

Huang et al. discuss the approach to galactorrhea in the outpatient setting. They comment that hyperprolactinemia is usually secondary to prolactinomas or iatrogenic (dopamine antagonists). More rare causes include hypothyroidism, renal insufficiency, pregnancy, and nipple stimulation.

Melmed et al. discuss the Endocrine Society's clinical guidelines for hyperprolactinemia. They conclude that dopamine agonists are 80-90% efficacious in the treatment of prolactinomas, with effective reduction in serum prolactin levels, as well as reduction in tumor size. Transsphenoidal surgery is reserved for patients with prolactinomas refractory to medical therapy.

Incorrect Answers:
Answer 1: Tamoxifen is a selective estrogen receptor modulator, used in to treat estrogen receptor positive breast cancer. This patient's presentation is not suggestive of breast cancer.
Answer 2: Leuprolide is a GnRH agonist which is can be used to suppress or stimulate the Hypothalamic-pituitary-gonadal axis, for example in the setting of precocious puberty.
Answer 3: Haloperidol is a typical antipsychotic which functions in part through CNS dopamine antagonism. Dopamine antagonism in the tuberoinfundibular tract by antipsychotics can result in iatrogenic hyperprolactinemia.
Answer 5: Carbidopa-Levodopa is dopamine replacement therapy for patients with Parkinson's Disease, it has no role to place in the treatment of hyperprolactinemia.

REFERENCES (2)
Authors
Rating
Please Rate Question Quality

4.0

  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon

(1)

Attach Treatment Poll
Treatment poll is required to gain more useful feedback from members.
Please enter Question Text
Please enter at least 2 unique options
Please enter at least 2 unique options
Please enter at least 2 unique options